熱門資訊> 正文

导管精密报告第一季度结果

2026-05-18 20:08

CREATD INC C/WTS 15/09/2025(TO PUR COM)(CRTDW) 0

Catheter Precision press release (VTAK): Q1 revenue grew 200% year-over-year to $432,000, compared to $143,000 in Q1 2025, driven by strong performance in both the Company’s core medical device segment and its newly launched aviation platform.
Net loss reduced to $1.7 million, compared to $4.0 million in Q1 2025

More on Catheter Precision

Creatd sells remaining stake in Fly Flyte to Catheter Precision for about $12 mln in cash and equity
Historical earnings data for Catheter Precision
Financial information for Catheter Precision

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。